Treatment results of radical radiotherapy of carcinoma uterine cervix using external beam radiotherapy and high dose rate intracavitary radiotherapy

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 4, 2010, Pages 482-486

  Azad, S K ^a   Choudhary, V ^a  

^a Department of Radiotherapy   (India)

Author keywords

Brachytherapy; carcinoma cervix; chemotherapy; radical radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CYSTITIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HIGH DOSE RATE INTRACAVITARY RADIOTHERAPY; HUMAN; HYDRONEPHROSIS; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; PROCTITIS; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; REACTION TIME; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT RESPONSE; UREMIA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 79952379403     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.77108     Document Type: Article

References (19)

1. rd ed. Philadelphia: Lee and Febiger; 1980. p. 720-31.
2. ICRU.org [internet] Bathesda, USA; International Commission on Radiation Units and measurement Report 38. Dose and volume specification for intracavitary, Inc 1985 Available from http://www.icru.org [Last accessed on 2009 Nov. 09].
3. Chen S W, Liang JA, Yeh LS, Yang SN, Shiau AC, Lin FJ. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2004;60:663-71.
4. Stryker JA, Bartholomew M, Velkey DE. Bladder and rectal complications following radiotherapy for cervix cancer. Gynecol Oncol 1988;29:1-11.
5. Saibishkumar E P, Patel FD, Sharma SC. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: An audit from India. Clin Oncol 2006;18:30-7. (Pubitemid 43056694)
6. Shakespeare T P, Lim KH, Lee KM, Back MF, Mukherjee R, Lu JD. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma. Int J Gynecol Cancer 2006;16:277-82.
7. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy society recommendations for highdose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:201-11. (Pubitemid 30488231)
8. Kosary CL. Cancer of cervix uteri. In: Ries LA, Young JL, Keel GE, Eisner M P, Lin YD, Horner MJ, editors. SEER Survival Monograph: Cancer Survival Among Adults: U. S. SEER Program, 1988-2001, Patient and Tumor Characteristics. NIH Pub. No. 07-6215. Bethesda, MD: National Cancer Institute, SEER Program; 2007. p. 111-22.
9. Eilic S, Ristic B. Five year results with HDR after loading in cervix cancer: Dependence on fractionation and dose. Strahlenther Onkol 1988;82:139-46.
10. Arai T, Nakano T, Morita S, Sakashita K, Nakamura YK, Fukuhisa K. High dose rate remote after loading intracavitary radiation therapy for cancer of the uterine cervix. Cancer 1992;69:175-80.
11. Shelke P, Roman TN, Souhami L, Freeman CR, Clark BG, Evans MD, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:803-9. (Pubitemid 23340289)
12. Jain VS, Singh KK, Shrivastava R, Somsundaram K V, Sarje MB, Jain SM. Radical radiotherapy treatment (EBRT+HDR-ICRT) of carcinoma cervix: Outcome in patients treated at a rural center in India. J Cancer Res Ther 2007;3:211-7 (Pubitemid 351264096)
13. Ito H, Kutuki S, Nishiguchi I, Shigematsu N, Kuribayashi T, Uematsu M, et al. Radiotherapy for cervical cancer with high-dose rate brachytherapy, correlation between tumor size, dose and failure. Radiother Oncol 1994;31:240-7.
14. Annual report on the results of treatment on the gynecological cancer. In: Patterson F, editor. Twentieth volume statements of results obtained in patients treated in 1979-1981. Inclusive 5 year survival up to 1986. Stockholm: International Federation of Gynecology and Obstretics; 1987. p. 52.
15. Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Lahousen M, et al. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir 192 high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1998;42:531-40. (Pubitemid 28501101)
16. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-9. (Pubitemid 23000770)
17. King M, McConkey C, Latief TN, Hartley A, Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side effects. Clin Oncol 2006;18:38-45. (Pubitemid 43056695)
18. Greek JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta analyses. Lancet 2001;358:781-6. (Pubitemid 32868726)
19. Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, et al. Clinical application of Intesity-modulated radiotherapy for locally advanced radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 2002;12:260-71. (Pubitemid 34755932)